Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) 49.9% HIGHER; Facet Biotech Corporation (Nasdaq: FACT) and Trubion today announced an agreement for the joint worldwide development and commercialization of TRU-016, a product candidate in phase 1 clinical development for chronic lymphocytic leukemia. Click here for the full report.

Dreams, Inc. (Amex: DRJ) 31.6% HIGHER; announced a partnership with the NBA’s Washington Wizards to launch the team’s official online store www.WashingtonWizardsStore.com.

Vonage (NYSE: VG) 24% LOWER; correcting once again today following a sharp 500% run-up from August 20 to August 26.

Cost Plus (Nasdaq: CPWM) 20.7% LOWER; reports Q2 loss from continuing